We are live on ! Find out more
CEI

Clark Estates Inc Portfolio holdings

AUM $434M
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+15%
3 Year Est. Return
+34.46%
5 Year Est. Return
+32.78%
10 Year Est. Return
+216.75%
AUM
$434M
AUM Growth
+$17.5M
Cap. Flow
-$3.16M
Cap. Flow %
-0.73%
Top 10 Hldgs %
52.76%
Holding
108
New
11
Increased
17
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$25.8M
2
HSIC icon
Henry Schein
HSIC
+$9.71M
3
UL icon
Unilever
UL
+$3.76M
4
BBY icon
Best Buy
BBY
+$2.9M
5
SONY icon
Sony
SONY
+$2.81M

Sector Composition

Rank Sector Weight
1 Healthcare 29.82%
2 Miscellaneous 21.8%
3 Technology 13.51%
4 Communication Services 11.78%
5 Consumer Staples 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$181B
$3.29M 0.76%
26,022
ZD icon
27
Ziff Davis
ZD
$1.91B
$3.27M 0.75%
62,425
-7,275
-10% -$329K
STRA icon
28
Strategic Education
STRA
$1.88B
$3.24M 0.75%
42,300
+14,700
+53% +$1.16M
WEX icon
29
WEX
WEX
$6.72B
$3.08M 0.71%
21,800
+6,700
+44% +$993K
TDC icon
30
Teradata
TDC
$2.68B
$3.04M 0.7%
87,600
-10,100
-10% -$307K
WKC icon
31
World Kinect Corp
WKC
$1.81B
$3.02M 0.7%
91,600
HRMY icon
32
Harmony Biosciences
HRMY
$2.28B
$2.96M 0.68%
81,300
FTDR icon
33
Frontdoor
FTDR
$5.71B
$2.95M 0.68%
38,000
AOS icon
34
A.O. Smith
AOS
$8.21B
$2.89M 0.67%
+46,000
New +$2.79M
DORM icon
35
Dorman Products
DORM
$3.84B
$2.87M 0.66%
21,000
MTCH icon
36
Match Group
MTCH
$9.54B
$2.85M 0.66%
74,800
INCY icon
37
Incyte
INCY
$25.2B
$2.83M 0.65%
25,000
EXPE icon
38
Expedia Group
EXPE
$39.5B
$2.81M 0.65%
11,000
-100
-0.9% -$23.8K
ADUS icon
39
Addus HomeCare
ADUS
$2.16B
$2.81M 0.65%
+28,000
New +$2.64M
VTRS icon
40
Viatris
VTRS
$18.8B
$2.72M 0.63%
171,566
GNTX icon
41
Gentex
GNTX
$4.78B
$2.65M 0.61%
+105,000
New +$2.48M
TNET icon
42
TriNet
TNET
$3.23B
$2.6M 0.6%
+52,500
New +$2.25M
CDW icon
43
CDW
CDW
$18.5B
$2.57M 0.59%
18,275
OSPN icon
44
OneSpan
OSPN
$610M
$2.54M 0.59%
177,000
BMY icon
45
Bristol-Myers Squibb
BMY
$136B
$2.48M 0.57%
43,000
OPCH icon
46
Option Care Health
OPCH
$3.58B
$2.47M 0.57%
+118,000
New +$2.74M
MMS icon
47
Maximus
MMS
$3.13B
$2.46M 0.57%
45,700
+18,562
+68% +$1.16M
KFY icon
48
Korn Ferry
KFY
$4.43B
$2.45M 0.56%
36,800
UPBD icon
49
Upbound Group
UPBD
$1.12B
$2.4M 0.55%
113,000
KBR icon
50
KBR
KBR
$4.79B
$2.39M 0.55%
69,200
+16,700
+32% +$582K

Similar funds

Clark Estates Inc's Q2 2026 Portfolio in Review

As of Q2 2026, Clark Estates Inc held 108 positions worth $434M, up 4.2% from $416M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clark Estates Inc's Q2 2026 filing shows 11 new, 17 increased, 16 reduced and 18 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M. The largest sale was Euclidean Fundamental Value ETF, an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 34% a quarter earlier, followed by Miscellaneous and Technology.

  • Clark Estates Inc's largest Q2 2026 buy was Vanguard FTSE Developed Markets ETF: 371,060 shares worth $26.4M.
  • Clark Estates Inc added most to Henry Schein in Q2 2026, an estimated $9.71M increase.
  • Clark Estates Inc's biggest Q2 2026 reduction was Euclidean Fundamental Value ETF, cutting an estimated $15M.
  • Clark Estates Inc fully exited Avanos Medical in Q2 2026, selling an estimated $11.8M.
  • Clark Estates Inc's ten largest holdings make up 53% of its $434M portfolio in Q2 2026.
  • Clark Estates Inc opened 11 new positions and closed 18 in Q2 2026.
  • Clark Estates Inc's portfolio value rose 4.2% quarter-over-quarter to $434M.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.